Ironwood Pharmaceuticals (irwd 1.5 06/15/26)
13F holders, Q1 2026 (March 31)2holders +1
1new positions
0sold out
$0.98avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Ironwood Pharmaceuticals (irwd 1.5 06/15/26) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Balyasny Asset Management L.P. ($18.0M) and Advisory Services Network, LLC ($17K).
- Company
- Ironwood Pharmaceuticals (irwd 1.5 06/15/26)
- CUSIP
- 46333XAH1
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $18.0M |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 18,405,000 shares bought, net +18,405,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Balyasny Asset Management L.P. | 0.04% | New | 18,405,000 | $18.0M |
| Advisory Services Network, LLC | 0.00% | No change | 18,000 | $17K |
"% of holder's portfolio" is IRONWOOD PHARMACEUTICALS (IRWD 1.5 06/15/26)'s weight in each manager's 13F, not the share of Ironwood Pharmaceuticals (irwd 1.5 06/15/26) the manager owns.